Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (701-710 of 849) with videos related to

Pageof 85
Sort By:
Hepatology (Baltimore, Md.)|September 26, 2020
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related CirrhosisLuis Calzadilla-Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Predicting liver-related events in NAFLD: A predictive modelLuis Calzadilla-Bertot, Gary P Jeffrey, Zhengyi Wang, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
Aging Cell|October 21, 2025
An Ad Libitum-Fed Diet That Matches the Beneficial Lifespan Effects of Caloric Restriction but Acts via Opposite Effects on the Energy-Splicing AxisAmanda E Brandon, Tamara Pulpitel, Carsten Schmitz-Peiffer, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2021
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementMohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
BMC Infectious Diseases|June 4, 2017
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover studyEdward J Gane, Edwin DeJesus, Ewa Janczewska, et al.
The Lancet. Gastroenterology & Hepatology|May 25, 2023
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S Bajaj, Ashok K Choudhury, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Pageof 85

Showing results (701-710 of 849) with videos related to

Sort By:
Pageof 85
Hepatology (Baltimore, Md.)|September 26, 2020
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related CirrhosisLuis Calzadilla-Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Predicting liver-related events in NAFLD: A predictive modelLuis Calzadilla-Bertot, Gary P Jeffrey, Zhengyi Wang, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
Aging Cell|October 21, 2025
An Ad Libitum-Fed Diet That Matches the Beneficial Lifespan Effects of Caloric Restriction but Acts via Opposite Effects on the Energy-Splicing AxisAmanda E Brandon, Tamara Pulpitel, Carsten Schmitz-Peiffer, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2021
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementMohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
BMC Infectious Diseases|June 4, 2017
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover studyEdward J Gane, Edwin DeJesus, Ewa Janczewska, et al.
The Lancet. Gastroenterology & Hepatology|May 25, 2023
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S Bajaj, Ashok K Choudhury, Qing Xie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Pageof 85